
Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing treatment on the NHS.
Ms Mehta, 36, from London, suffers from beta thalassaemia, a condition where her body struggles to produce sufficient haemoglobin – the vital protein in red blood cells responsible for oxygen transport.